Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:
• Adults aged 18-40 years
• Spherical equivalent of -1.00 to -10.00 D
• Stable refraction for at least 12 months
• Informed consent provided
Locations
Other Locations
China
Beijing New Vision Eye Hospital
RECRUITING
Beijing
Beijing Visionly Plus Eye Hospital
RECRUITING
Beijing
Contact Information
Primary
Peng ZHOU, M.D.
drzhoupeng@gmail.com
+86-18801871108
Time Frame
Start Date: 2025-01-20
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 1000
Treatments
Experimental: SMILE Group
Standard Small Incision Lenticule Extraction (SMILE) procedure using VisuMax laser
Experimental: ICL group
Implantable Collamer Lens (ICL) implantation using the STAAR Surgical Visian ICL
Experimental: Wavelight Plus Alcon Group
Laser vision correction using the Wavelight Plus Alcon system
Related Therapeutic Areas
Sponsors
Collaborators: Shanghai Parkway Hospital, Beijing New Vision Eye Hospital, High Myopia Control Alliance (HIMALAYA)
Leads: Beijing Visionly Plus Eye Hospital